Quadrant Capital Group’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,814
Closed -$11.9K 2767
2024
Q1
$11.9K Buy
1,814
+1,475
+435% +$9.68K ﹤0.01% 2041
2023
Q4
$2.2K Buy
+339
New +$2.2K ﹤0.01% 2460